Lancet Capital is a venture capital firm in Massachusetts that focuses on investing in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics and diagnostic systems. Founded 1998 in Cambridge, Massachusetts, United States by George Sing and William Golden. Its portfolio companies include Biodel and Stentor. Lancet invests in researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. It is an SBIC that is affiliated with an academic medical center and aims to commercialize technologies in the biomedical field.
Timeline
People
George Sing
Managing Director & Co-Founder
William Golden
Managing Director & Co-Founder
Further reading
Documentaries, videos and podcasts
Companies
Biodel
Noveome Biotherapeutics
Stentor
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 3
Melanie Manipula
Helping organize knowledge. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME